Pharmaceutical Chemicals Market (By Product: Basic Building Blocks, Advanced intermediates, and Active ingredients; By Application: Cardiovascular, Neurology, Oncology, Infectious diseases, Metabolic system, Diabetes, Respiratory diseases, Gastrointestinal diseases, Musculoskeletal diseases, and Other) - Global Market Size, Share, Trends Analysis, Segment Forecasts, Regional Outlook 2023 - 2032
The global pharmaceutical chemicals market size accounted for USD 108 billion in 2022 and is predicted to reach USD 205.6 billion by the end of 2032, representing an impressive CAGR of 6.7% during the forecast period 2023 to 2032. Increasing demand for advanced drugs and rise in demand for the active pharmaceutical chemicals are major growth driver of pharmaceutical chemicals market.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. pharmaceutical chemicals market size was valued at USD 24.43 billion in 2022 and is estimated to reach around USD 46.07 billion by 2032, growing at a CAGR of 6.60% from 2023 to 2032.
The research report covers key trends and prospects of pharmaceutical chemicals products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, pharmaceutical chemicals market is conquered by North America owing to favorable government mandates for the production of the pharmaceutical chemicals, coupled with increasing research and development activities for production of pharmaceutical chemicals in the countries of this region, especially in the United States. Asia-Pacific is expected to register the fast growth rate, on account of increasing API production and growing investment in research and development sector by key market players in the region. Also, increasing prevalence of chronic diseases is anticipated to drive growth of the target industry in the countries of Asia Pacific region. Further, increasing population in the Asian countries is responsible for the high demand for pharmaceutical chemicals in the region. Latin America and the African and Middle Eastern region will display noticeable growth over the forecast period.
Emerging applications of the pharmaceutical chemicals are projected to generate lucrative growth opportunities for the major players operating in the global pharmaceutical chemicals market. Developments of new pharmaceutical drugs, coupled with evolving markets are majors trends observed in the global pharmaceutical chemical market. This trend is expected to continue and will boost growth of the target market in the near future. Increasing healthcare expenditure in emerging markets is influencing the worldwide business strategies of pharmaceutical chemical market owing to high profitability. The attention of these emerging markets is favoring towards health concerns affecting individuals owing to which they are focusing on increasing investment and launching advanced products across the globe. The manufacturing costs of pharmaceutical drugs can be reduced by innovations, hence the key players operating in the target industries are constantly increasing healthcare expenditure. Further, major companies in global industry are collaborating in order to competitive edge in the global market.
| Report Highlights | Details |
| Market Size in 2023 | USD 114.7 Billion |
| Market Size by 2032 | USD 205.6 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 6.7% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Product Type, Application Type, Region Outlook |
| Companies Mentioned | BASF, Porton Fine Chemicals, Lonza, Johnson Matthey, Dishman, Lanxess, Vertellus Holdings, Jubilant Life Sciences, Hikal, Abbott |
Basic building blocks Segment Reported Foremost Market Stake in 2022
Basic building blocks segment recorded the prime market share in the global pharmaceutical chemicals market by product in 2020. The Advanced intermediates product segment is predictable to rise at a noteworthy CAGR during the forecast time-frame.
Cardiovascular segment is projected to dominate the Application Segment of Pharmaceutical Chemicals Market Revenue
On the basis of application segment the global market is segregated into gastrointestinal diseases, infectious diseases, musculoskeletal diseases, oncology, respiratory diseases, diabetes, neurology, metabolic system, cardiovascular, other. The cardiovascular application segment is expected to dominate in terms of revenue over the forecast time frame. The growth is attributed to the increasing use of pharmaceutical chemicals for the treatment of blood vessels and heart diseases across the globe. Increasing prevalence of heart diseases is primarily responsible for the greater market share of cardiovascular in the application segment of the pharmaceutical chemicals market. Oncology segment will expand at a significant CAGR during the forecast time-frame.
The companies focusing on research and development are expected to lead the global pharmaceutical chemicals market. Leading competitors contending in global pharmaceutical chemicals market are as follows:
In order to better recognize the current status of pharmaceutical chemicals, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the pharmaceutical chemicals market. This research study bids qualitative and quantitative insights on pharmaceutical chemicals market and assessment of market size and growth trend for potential global market segments.
Major Market Segments Covered:
By Product
By Application
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Pharmaceutical Chemicals Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Pharmaceutical Chemicals Market
5.1. Covid-19: Pharmaceutical Chemicals Industry Impact
5.2. Pharmaceutical Chemicals Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pharmaceutical Chemicals Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pharmaceutical Chemicals Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Pharmaceutical Chemicals Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing generic population
6.1.1.2. Increasing demand for preventive healthcare
6.1.2. Market Restraints
6.1.2.1. Strict environmental standard and high cost of raw materials
6.1.3. Market Opportunities
6.1.3.1. Emerging markets
Chapter 7. Global Pharmaceutical Chemicals Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pharmaceutical Chemicals Market Revenue by Market Players (2017 - 2020)
7.1.1.2. Pharmaceutical Chemicals Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Pharmaceutical Chemicals Market, By Product
8.1. Pharmaceutical Chemicals Market, by Product, 2023-2032
8.1.1. Basic building blocks
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Advanced intermediates
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Active ingredients
8.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Pharmaceutical Chemicals Market, By Application
9.1. Pharmaceutical Chemicals Market, by Application, 2023-2032
9.1.1. Cardiovascular
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Neurology
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Infectious diseases
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. Metabolic system
9.1.5.1. Market Revenue and Forecast (2021-2032)
9.1.6. Diabetes
9.1.6.1. Market Revenue and Forecast (2021-2032)
9.1.7. Respiratory diseases
9.1.7.1. Market Revenue and Forecast (2021-2032)
9.1.8. Gastrointestinal diseases
9.1.8.1. Market Revenue and Forecast (2021-2032)
9.1.9. Musculoskeletal diseases
9.1.9.1. Market Revenue and Forecast (2021-2032)
9.1.10. Other
9.1.10.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Pharmaceutical Chemicals Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product(2021-2032)
10.1.2. Market Revenue Forecast by Application (2021-2032)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2021-2032)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2021-2032)
10.2. Europe
10.2.1. Market Revenue Forecast by Product (2021-2032)
10.2.2. Market Revenue Forecast by Application (2021-2032)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2021-2032)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2021-2032)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2021-2032)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2021-2032)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product (2021-2032)
10.3.2. Market Revenue Forecast by Application (2021-2032)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2021-2032)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2021-2032)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2021-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2021-2032)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product (2021-2032)
10.4.2. Market Revenue Forecast by Application (2021-2032)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2021-2032)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2021-2032)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product (2021-2032)
10.5.2. Market Revenue Forecast by Application (2021-2032)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2021-2032)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2021-2032)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2021-2032)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2021-2032)
Chapter 11. Company Profiles
11.1. BASF
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2017-2020)
11.1.4. Recent Developments and Strategies
11.2. Lonza
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2017-2020)
11.2.4. Recent Developments and Strategies
11.3. Porton Fine Chemicals
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2017-2020)
11.3.4. Recent Developments and Strategies
11.4. Dishman
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2017-2020)
11.4.4. Recent Developments and Strategies
11.5. Lanxess
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2017-2020)
11.5.4. Recent Developments and Strategies
11.6. Johnson Matthey
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2017-2020)
11.6.4. Recent Developments and Strategies
11.7. Vertellus Holdings
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2017-2020)
11.7.4. Recent Developments and Strategies
11.8. Jubilant Life Sciences
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2017-2020)
11.8.4. Recent Developments and Strategies
11.9. Hikal
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2017-2020)
11.9.4. Recent Developments and Strategies
11.10. Abbott
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2017-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
